Literature DB >> 16611328

C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats.

K Minami1, K Murata, C-Y Lee, K Fox-Talbot, B A Wasowska, M D Pescovitz, W M Baldwin.   

Abstract

Antibody-mediated rejection of human cardiac transplants is correlated with C4d deposits and macrophage infiltrates in capillaries of endomyocardial biopsies. We produced an antibody to rat C4d to study C4d deposition and clearance in Lewis rats that were sensitized with a blood transfusion from DA rats 7, 14 or 21 days before cardiac transplantation. Cyclosporin A (CsA) immunosuppression was initiated after transplantation at a dose that inhibited graft rejection, antibody production and C4d deposition in unsensitized recipients. Blood transfusion elicited high levels of circulating IgG alloantibodies, predominantly of the complement-activating IgG2b subclass, that peaked 14 days after transplantation. At this time, macrophages accumulated in capillaries, and C4d deposits were diffuse and intense on arteries, capillaries and veins. Grafts that survived 90 days in sensitized recipients still had deposits of C4d that were associated with increased interstitial fibrosis and vasculopathy in arteries. Clearance of C4d was determined by retransplanting DA cardiac allografts from Lewis recipients back to DA recipients. C4d deposits were decreased to minimal levels within 5 days after retransplantation. Thus, C4d deposition is not limited to the capillaries, but extends throughout the arterial tree, and despite formation of a covalent bond, C4d is cleared within days.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611328     DOI: 10.1111/j.1600-6143.2006.01281.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  19 in total

Review 1.  B cells in cardiac transplants: from clinical questions to experimental models.

Authors:  William M Baldwin; Marc K Halushka; Anna Valujskikh; Robert L Fairchild
Journal:  Semin Immunol       Date:  2011-09-19       Impact factor: 11.130

Review 2.  [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions].

Authors:  Georg Böhmig
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

3.  Antibody to human leukocyte antigen triggers endothelial exocytosis.

Authors:  Munekazu Yamakuchi; Nancy C Kirkiles-Smith; Marcella Ferlito; Scott J Cameron; Clare Bao; Karen Fox-Talbot; Barbara A Wasowska; William M Baldwin; Jordan S Pober; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

4.  Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.

Authors:  Phillip H Horne; Jason M Zimmerer; Mason G Fisher; Keri E Lunsford; Gyongyi Nadasdy; Tibor Nadasdy; Nico van Rooijen; Ginny L Bumgardner
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

Review 5.  Antibody-mediated rejection: emergence of animal models to answer clinical questions.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

6.  Platelets in early antibody-mediated rejection of renal transplants.

Authors:  Hsiao-Hsuan Kuo; Ran Fan; Nina Dvorina; Andres Chiesa-Vottero; William M Baldwin
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

Review 7.  New concepts of complement in allorecognition and graft rejection.

Authors:  Barbara A Wasowska; Chih-Yuan Lee; Marc K Halushka; William M Baldwin
Journal:  Cell Immunol       Date:  2007-10-24       Impact factor: 4.868

8.  C4d deposition and cellular infiltrates as markers of acute rejection in rat models of orthotopic lung transplantation.

Authors:  Kazunori Murata; Takekazu Iwata; Shinji Nakashima; Karen Fox-Talbot; Zhiping Qian; David S Wilkes; William M Baldwin
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

Review 9.  Complement-mediated microvascular injury leads to chronic rejection.

Authors:  Mohammad A Khan; Mark R Nicolls
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  Complement fragments are biomarkers of antibody-mediated endothelial injury.

Authors:  Erik Stites; Brandon Renner; Jennifer Laskowski; Moglie Le Quintrec; Zhiying You; Brian Freed; James Cooper; Diana Jalal; Joshua M Thurman
Journal:  Mol Immunol       Date:  2019-12-26       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.